The Epidemiology and Etiology of Acute Gastroenteritis Among Estonian Children After Introduction of Rotavirus Vaccines
NCT02662543 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2260
Last updated 2016-12-21
Summary
This study is designed to estimate the changes in the etiology and epidemiology of acute gastroenteritis in children aged less than 18 years after the implementation of rotavirus vaccine in the Estonian national immunization program in July 2014.
Conditions
- Rotavirus Infection
Sponsors & Collaborators
-
University of Tartu
lead OTHER
Principal Investigators
-
Irja Lutsar, PhD · Institute of Microbiology, University of Tartu
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-02-28
- Primary Completion
- 2018-08-31
- Completion
- 2020-08-31
Countries
- Estonia
Study Locations
More Related Trials
-
Impact of Rotavirus Vaccine Introduction for South Australian Children
NCT01472575 ·Status: UNKNOWN
-
Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France.
NCT00740935 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama
NCT00653198 ·Status: COMPLETED
-
Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study
NCT02542462 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of RotarixTM Vaccine in Children Aged Between 12 Weeks to < 5 Years, Hospitalised for Severe Gastroenteritis
NCT01978223 ·Status: WITHDRAWN
-
Effectiveness of Monovalent Rotavirus Vaccine (RV1)
NCT01871038 ·Status: COMPLETED
-
Vaccine Effectiveness of RV1 in a Naïve Population
NCT01467037 ·Status: COMPLETED
-
Observational Study on Rotavirus Gastroenteritis Epidemiology, Impact of Lyophilised vs. Liquid Formulation of Rotarix™
NCT01435967 ·Status: COMPLETED
-
Improving Rotavirus Vaccine Immune Response
NCT01825109 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotarix Vaccination
NCT01915888 ·Status: COMPLETED
-
Canadian Rotavirus Surveillance Through the Immunization Monitoring Program Active (IMPACT)
NCT01633190 ·Status: UNKNOWN
-
Effectiveness of Human Rotavirus Vaccine, Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants
NCT00655187 ·Status: COMPLETED
-
Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in Brazil
NCT01177657 ·Status: COMPLETED
-
Glycan Attachment Specificity, Toward ROtavirus Vaccine IMprovement GASTROVIMc (Clinical Investigation)
NCT02902445 ·Status: COMPLETED
-
ROTATEQ Reexamination Study (V260-037)
NCT01074242 ·Status: COMPLETED
-
Phase Three Clinical Trials of Trivalent Rotavirus Genetic Reassortment Vaccine
NCT01738074 ·Status: UNKNOWN ·Phase: PHASE3
-
Surveillance Study to Estimate the Proportion of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania
NCT01253967 ·Status: COMPLETED
-
Surveillance of Rotavirus Gastroenteritis in Children <5 Years
NCT01363726 ·Status: UNKNOWN
-
Rotavirus Gastroenteritis and Vaccine Usage in Rhode Island
NCT01026779 ·Status: COMPLETED
-
ROTA-biotic: Measuring the Impact of Rotavirus Vaccines on Paediatric Antibiotic Usage
NCT06882070 ·Status: COMPLETED
-
Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana
NCT01575197 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Rotavirus Immunization in Nicaragua
NCT01133808 ·Status: COMPLETED
-
Safety and Immunogenicity Study of the Tetravalent Rotavirus Vaccine
NCT01061658 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Optimising Rotavirus Vaccine in Aboriginal Children
NCT02941107 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis
NCT01733862 ·Status: COMPLETED